|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Pulmonary and Critical Care Medicine Division (Drs. Ibrahim and Kollef, and Ms. Ward), Department of Internal Medicine, Washington University School of Medicine; and the Department of Nursing (Ms. Sherman), Barnes-Jewish Hospital, Saint Louis, MO.
Correspondence to: Marin H. Kollef, MD, FCCP, Pulmonary and Critical Care Medicine, Washington University School of Medicine, Campus Box 8052, 660 South Euclid, St.Louis, MO 63110; e-mail: mkollef{at}pulmonary.wustl.edu
Study objective: To compare the clinical outcomes of critically ill patients developing early-onset nosocomial pneumonia (NP; ie, within 96 h of ICU admission) and late-onset NP (ie, occurring after 96 h of ICU admission).
Design: Prospective cohort study.
Setting: A medical ICU and a surgical ICU from a university-affiliated urban teaching hospital.
Patients: Between July 1997 and November 1998, 3,668 patients were prospectively evaluated.
Intervention: Prospective patient surveillance and data collection.
Results: Four hundred twenty patients (11.5%) developed NP. Early-onset NP was observed in 235 patients (56.0%), whereas 185 patients (44.0%) developed late-onset NP. Among patients with early onset NP, 114 patients (48.5%) spent at least 24 h in the hospital prior to ICU admission, compared to 57 patients (30.8%) with late-onset NP (p = 0.001). One hundred eighty-three patients (77.9%) with early-onset NP received antibiotics prior to the development of NP, as compared to 162 patients (87.6%) with late-onset NP (p = 0.010). The most common pathogens associated with early-onset NP were Pseudomonas aeruginosa (25.1%), oxacillin-sensitive Staphylococcus aureus (OSSA; 17.9%), oxacillin-resistant S aureus (ORSA; 17.9%), and Enterobacter species (10.2%). P aeruginosa (38.4%), ORSA (21.1%), Stenotrophomonas maltophilia (11.4%), OSSA (10.8%), and Enterobacter species (10.3%) were the most common pathogens associated with late-onset NP. The ICU length of stay was significantly longer for patients with early-onset NP (10.3 ± 8.3 days; p < 0.001) and late-onset NP (21.0 ± 13.7 days; p < 0.001), as compared to patients without NP (3.5 ± 3.2 days). Hospital mortality was significantly greater for patients with early-onset NP (37.9%; p = 0.001) and late-onset NP (41.1%; p = 0.001) compared to patients without NP (13.1%).
Conclusions: Both early-onset and late-onset NP are associated with increased hospital mortality rates and prolonged lengths of stay. The pathogens associated with NP were similar for both groups. This may be due, in part, to the prior hospitalization and use of antibiotics in many patients developing early-onset NP. These data suggest that P aeruginosa and ORSA can be important pathogens associated with early-onset NP in the ICU setting. Additionally, clinicians should be aware of the common microorganisms associated with both early-onset NP and late-onset NP in their hospitals in order to avoid the administration of inadequate antimicrobial treatment.
Key Words: clinical outcomes critical care hospital mortality ICU infection nosocomial pneumonia risk factors
This article has been cited by other articles:
![]() |
S. M. Koenig and J. D. Truwit Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention Clin. Microbiol. Rev., October 1, 2006; 19(4): 637 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Babcock, J. E. Zack, T. Garrison, E. Trovillion, M. Jones, V. J. Fraser, and M. H. Kollef An Educational Intervention to Reduce Ventilator-Associated Pneumonia in an Integrated Health System: A Comparison of Effects Chest, June 1, 2004; 125(6): 2224 - 2231. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Wunderink, J. Rello, S. K. Cammarata, R. V. Croos-Dabrera, and M. H. Kollef Linezolid vs Vancomycin: Analysis of Two Double-Blind Studies of Patients With Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia Chest, November 1, 2003; 124(5): 1789 - 1797. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Mehta and M. S. Niederman Nosocomial Pneumonia in the Intensive Care Unit: Controversies and Dilemmas J Intensive Care Med, July 1, 2003; 18(4): 175 - 188. [Abstract] [PDF] |
||||
![]() |
J. Rello, D. A. Ollendorf, G. Oster, M. Vera-Llonch, L. Bellm, R. Redman, and M. H. Kollef Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database Chest, December 1, 2002; 122(6): 2115 - 2121. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Spain Ventilator-Associated Pneumonia and Surgical Patients Chest, May 1, 2002; 121(5): 1390 - 1391. [Full Text] [PDF] |
||||
![]() |
J. Chastre and J.-Y. Fagon Ventilator-associated Pneumonia Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 867 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Ewig, T Bauer, and A Torres The pulmonary physician in critical care * 4: Nosocomial pneumonia Thorax, April 1, 2002; 57(4): 366 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Olson, B. G. Harmon, and M. H. Kollef Silver-Coated Endotracheal Tubes Associated With Reduced Bacterial Burden in the Lungs of Mechanically Ventilated Dogs Chest, March 1, 2002; 121(3): 863 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rello, J. A. Paiva, J. Baraibar, F. Barcenilla, M. Bodi, D. Castander, H. Correa, E. Diaz, J. Garnacho, M. Llorio, et al. International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-Associated Pneumonia Chest, September 1, 2001; 120(3): 955 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Ibrahim, L. Tracy, C. Hill, V. J. Fraser, and M. H. Kollef The Occurrence of Ventilator-Associated Pneumonia in a Community Hospital : Risk Factors and Clinical Outcomes Chest, August 1, 2001; 120(2): 555 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Franquet Imaging of pneumonia: trends and algorithms Eur. Respir. J., July 1, 2001; 18(1): 196 - 208. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |